Towards an increasingly molecular-based, patient-oriented treatment of acute myeloid leukemia. Haematologica 1996; 81(1):1-2; https://doi.org/10.3324/%x.
To create an adaptation, translation, or derivative of the
original work, for commercial e-prints and printed articles further permission is required.
For information contact: marketing@haematologica.org
Other types of copyright management, can be agreed with the Editorial office.
